6836-21-1 Usage
General Description
7-Methoxy-1-naphthaleneacetic acid ethyl ester is a chemical compound with the molecular formula C14H14O3. It is an ethyl ester derivative of 7-methoxy-1-naphthaleneacetic acid, which is a compound with potential anti-inflammatory and anti-cancer properties. This chemical is commonly used in pharmaceutical research and drug development as an intermediate in the synthesis of potential pharmaceutical agents. It is known for its ability to inhibit the production of prostaglandins and leukotrienes, which are involved in the inflammatory response. Additionally, it has shown potential as an anti-cancer agent by suppressing the growth of cancer cells. Overall, 7-Methoxy-1-naphthaleneacetic acid ethyl ester is a compound with promising pharmacological properties and is being studied for its potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 6836-21-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,8,3 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6836-21:
(6*6)+(5*8)+(4*3)+(3*6)+(2*2)+(1*1)=111
111 % 10 = 1
So 6836-21-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H16O3/c1-3-18-15(16)9-12-6-4-5-11-7-8-13(17-2)10-14(11)12/h4-8,10H,3,9H2,1-2H3
6836-21-1Relevant articles and documents
A Practical synthesis of (7-methoxynaphth-l-yl)acetic acid
Tang, Jia-Deng,Cen, Jun-Da
, p. 164 - 168 (2009)
-
Modular Synthesis of Arylacetic Acid Esters, Thioesters, and Amides from Aryl Ethers via Rh(II)-Catalyzed Diazo Arylation
Best, Daniel,Jean, Micka?l,Van De Weghe, Pierre
, p. 7760 - 7770 (2016/09/12)
One-pot formation of arylacetic acid esters, thioesters, and amides via Rh(II)-catalyzed arylation of a Meldrum's acid-derived diazo reagent with electron-rich arenes is described. The methodology was used to efficiently synthesize an anticancer compound.
PROCESS FOR THE PREPARATION OF AGOMELATINE
-
, (2012/06/15)
The present invention relates to a process for the manufacture of N-[2-(7-methoxy-1-naphthalenyl) ethyl]acetamide (Agomelatine) with improved yield and reduced level of N- acetyl-N-[2-(7-methoxy-1-naphthalenyl) ethyl]acetamide impurity.